Lunai Bioworks (LNAI) Total Liabilities (2011 - 2026)
Lunai Bioworks (LNAI) posted quarterly Total Liabilities of $19.4 million for Q1 2026, down 33.83% year-over-year from $29.3 million in Q1 2025, and down 3.96% quarter-over-quarter from $20.2 million in Q4 2025.
Lunai Bioworks (LNAI) Total Liabilities (2011 - 2026) Analysis & Trends
Lunai Bioworks' Total Liabilities history runs 16 years deep, the most recent figure standing at $19.4 million for Q1 2026.
- In Q1 2026, Total Liabilities fell 33.83% year-over-year to $19.4 million; the TTM figure through Mar 2026 stood at $19.4 million (down 33.83% YoY), while the FY2025 annual figure was $29.6 million, down 5.04% from the prior year.
- Total Liabilities for Q1 2026 stood at $19.4 million, down from $20.2 million in the prior quarter.
- The five-year high for Total Liabilities was $43.7 million in Q1 2024, with the low at $10.8 million in Q3 2023.
- The 5-year median for Total Liabilities is $19.4 million (2026), against an average of $20.8 million.
- The sharpest annual moves came in 2022 and 2024: Total Liabilities plunged 93.08% in 2022, then soared 246.63% in 2024.
- Lunai Bioworks' Total Liabilities stood at $13.4 million in 2022, then climbed by 7.84% to $14.4 million in 2023, then soared by 103.02% to $29.3 million in 2024, then sank by 30.96% to $20.2 million in 2025, then fell by 3.96% to $19.4 million in 2026.
- Business Quant data shows LNAI's Total Liabilities at $19.4 million in Q1 2026, $20.2 million in Q4 2025, and $20.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.05 Bn | 131.20 Bn | 2.84 Bn | 7.18 Bn |
| 2 | Regeneron Pharmaceuticals | 85.99 Bn | 78.00 Bn | 3.93 Bn | 10.02 Bn |
| 3 | Argenx Se | 65.49 Bn | 60.31 Bn | 1.37 Bn | 1.62 Bn |
| 4 | Moderna | 56.79 Bn | 51.65 Bn | 52.00 Mn | 4.20 Bn |
| 5 | BeOne Medicines | 42.14 Bn | 37.05 Bn | 1.53 Bn | 4.00 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.27 Bn | 992.69 Mn | 4.20 Bn |
| 7 | BioNTech SE | 27.71 Bn | 9.32 Bn | 668.28 Mn | 3.22 Bn |
| 8 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 1.35 Bn |
| 9 | Royalty Pharma | 27.35 Bn | 26.51 Bn | - | 10.03 Bn |
| 10 | Lunai Bioworks | 6.92 Mn | 3.76 Mn | 20,942.00 | 19.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 19.41 Mn |
| Dec 31, 2025 | 20.22 Mn |
| Sep 30, 2025 | 20.00 Mn |
| Jun 30, 2025 | 29.58 Mn |
| Mar 31, 2025 | 29.34 Mn |
| Dec 31, 2024 | 29.28 Mn |
| Sep 30, 2024 | 23.75 Mn |
| Jun 30, 2024 | 31.15 Mn |
| Mar 31, 2024 | 43.68 Mn |
| Dec 31, 2023 | 14.42 Mn |
| Sep 30, 2023 | 10.82 Mn |
| Jun 30, 2023 | 11.80 Mn |
| Mar 31, 2023 | 12.60 Mn |
| Dec 31, 2022 | 13.37 Mn |
| Sep 30, 2022 | 12.75 Mn |
| Jun 30, 2022 | 12.01 Mn |
| Mar 31, 2022 | 18.86 Mn |
| Dec 31, 2021 | 17.52 Mn |
| Sep 30, 2021 | 184.06 Mn |
| Jun 30, 2021 | 14.94 Mn |